Time to TAVI: streamlining the pathway to treatment

Author:

Hewitson Lynsey JaneORCID,Cadiz Suzane,Al-Sayed Sameeha,Fellows Sarah,Amin Alaaeldin,Asimakopoulos George,Barnes Edward,Beale Andrew,Browne SuzyORCID,Chandrasekaran Badrinathan,Dalby Miles,Foley PaulORCID,Hawkins Mark,Haynes Douglas,Heng Ee Ling,Hyde Tom,Kabir Tito,Khavandi Ali,Mirsadraee Saeed,McCrea William,Petrou Mario,Senior Roxy,Smith David,Smith Robert,Spartera Marco,Wamil Malgorzata,Panoulas Vasileios,Rahbi Hazim

Abstract

IntroductionSevere aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. However, this has been associated with delays to treatment, in breach of British Cardiovascular Intervention Society targets. A novel pathway with emphasis on comprehensive patient workup at a local centre, alongside close collaboration with a Heart Valve Centre, may help reduce the time to TAVI.MethodsThe centre performing local workup implemented a novel TAVI referral pathway. Data were collected retrospectively for all outpatients referred for consideration of TAVI to a Heart Valve Centre from November 2020 to November 2021. The main outcome of time to TAVI was calculated as the time from Heart Valve Centre referral to TAVI, or alternative intervention, expressed in days. For the centre performing local workup, referral was defined as the date of multidisciplinary team discussion. For this centre, a total pathway time from echocardiographic diagnosis to TAVI was also evaluated. A secondary outcome of the proportion of referrals proceeding to TAVI at the Heart Valve Centre was analysed.ResultsMean±SD time from referral to TAVI was significantly lower at the centre performing local workup, when compared with centres with traditional referral pathways (32.4±64 to 126±257 days, p<0.00001). The total pathway time from echocardiographic diagnosis to TAVI for the centre performing local workup was 89.9±67.6 days, which was also significantly shorter than referral to TAVI time from all other centres (p<0.003). Centres without local workup had a significantly lower percentage of patients accepted for TAVI (49.5% vs 97.8%, p<0.00001).DiscussionA novel TAVI pathway with emphasis on local workup within a non-surgical centre significantly reduced both the time to TAVI and rejection rates from a Heart Valve Centre. If adopted across the other centres, this approach may help improve access to TAVI.

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. 2021 ESC/EACTS Guidelines for the management of valvular heart disease

2. Ali N , Faour A , Rawlins J , et al . "Valve for life”: tackling the deficit in transcatheter treatment of heart valve disease in the UK. Open Heart 2021;8:e001547. doi:10.1136/openhrt-2020-001547

3. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?

4. Burden of valvular heart diseases: a population-based study

5. British cardiovascular intervention society (BCIS) . Service specification for transcatheter aortic valve implantation. 2019. Available: https://www.bcis.org.uk/resources/bcis-guidance-documents/service-specification-for-transcatheter-aortic-valve-implantation-tavi [Accessed 07 Jul 2022].

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Transcatheter Aortic Valve Replacement Without Onsite Cardiac Surgery;JACC: Cardiovascular Interventions;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3